The DOI matches its Crossref record.
Prostate Cancer: Identification with Combined Diffusion-weighted MR Imaging and 3D1H MR Spectroscopic Imaging—Correlation with Pathologic Findings1
Abstract
PURPOSE: To retrospectively measure the mean apparent diffusion coefficient (ADC) with diffusion-weighted magnetic resonance (MR) imaging and the mean metabolic ratio (MET) with three-dimensional (3D) hydrogen 1 ((1)H) MR spectroscopic imaging in regions of interest (ROIs) drawn over benign and malignant peripheral zone (PZ) prostatic tissue and to assess ADC, MET, and combined ADC and MET for identifying malignant ROIs, with whole-mount histopathologic examination as the reference standard. MATERIALS AND METHODS: The institutional review board approved this HIPAA-compliant retrospective study and issued a waiver of informed consent. From among 61 consecutive patients with prostate cancer, 38 men (median age, 61 years; range, 42-72 years) who underwent 1.5-T endorectal MR imaging before radical prostatectomy and who fulfilled all inclusion criteria of no prior hormonal or radiation treatment and at least one PZ lesion (volume, >0.1 cm(3)) at whole-mount pathologic examination were included. ADC maps were generated from diffusion-weighted MR imaging data, and MET maps of (choline plus polyamine plus creatine)/citrate were calculated from 3D (1)H MR spectroscopic imaging data. ROIs in the PZ identified by matching pathologic slides with T2-weighted images were overlaid on MET and ADC maps. Areas under the receiver operating characteristic curves (AUCs) were used to evaluate accuracy. RESULTS: The mean ADC +/- standard deviation, (1.39 +/- 0.23) x 10(-3) mm(2)/sec, and mean MET (0.92 +/- 0.32) for malignant ROIs differed significantly from the mean ADC, (1.69 +/- 0.24) x 10(-3) mm(2)/sec, and mean MET (0.73 +/- 0.18) for benign ROIs (P < .001 for both). In distinguishing malignant ROIs, combined ADC and MET (AUC = 0.85) performed significantly better than MET alone (AUC = 0.74; P = .005) and was also better than ADC alone (AUC = 0.81), although the difference was not statistically significant (P = .09). CONCLUSION: The combination of ADC and MET performs significantly better than MET for differentiating between benign and malignant ROIs in the PZ.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Prostate Cancer: Multiparametric MR Imaging for Detection, Localization, and Staging
Hoeks, C. M. A., Barentsz, J. O., Hambrock, T., Yakar, D., Somford, D. M., Heijmink, S. W. T. P. J., Scheenen, T. W. J., Vos, P. C., Huisman, H., van Oort, I. M., et al. (2011) · Radiology · doi:10.1148/radiol.11091822 · Cited by 677
Wibmer, A., Hricak, H., Gondo, T., Matsumoto, K., Veeraraghavan, H., Fehr, D., Zheng, J., Goldman, D., Moskowitz, C., Fine, S. W., et al. (2015) · European Radiology · doi:10.1007/s00330-015-3701-8 · Cited by 391
Self-citationFehr, D., Veeraraghavan, H., Wibmer, A., Gondo, T., Matsumoto, K., Vargas, H. A., Sala, E., Hricak, H., & Deasy, J. O. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1505935112 · Cited by 382
Self-citationPlathow, C., & Weber, W. A. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.045930 · Cited by 328
Metadata
- Authors
- Mazaheri, Y., Shukla-Dave, A., Hricak, H., Fine, S. W., Zhang, J., Inurrigarro, G., Moskowitz, C. S., Ishill, N. M., Reuter, V. E., Touijer, K., Zakian, K. L., & Koutcher, J. A.
- Venue
- Radiology
- Published
- 2008-02
- Volume
- 246
- Issue
- 2
- Pages
- 480-488
- ISSN
- 0033-8419 (ISSN-L)
- 1527-1315
- OpenAlex
- W2124577350
- Cited by
- 199
- References
- 0
- FWCI
- 28.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prostate Cancer: Identification with Combined Diffusion-weighted MR Imaging and 3D1H MR Spectroscopic Imaging—Correlation with Pathologic Findings1. https://app.cochat.ai/papers/10.1148/radiol.2462070368
- The paper
- Mazaheri, Y., Shukla-Dave, A., Hricak, H., Fine, S. W., Zhang, J., Inurrigarro, G., Moskowitz, C. S., Ishill, N. M., Reuter, V. E., Touijer, K., Zakian, K. L., & Koutcher, J. A. (2008). Prostate Cancer: Identification with Combined Diffusion-weighted MR Imaging and 3D1H MR Spectroscopic Imaging—Correlation with Pathologic Findings1. Radiology. https://doi.org/10.1148/radiol.2462070368
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.